Clinical studies have shown that the CD44high/CD24low phenotype was more prevalent in triple negative (ER/PR- and HER2-) breast cancer (TNBC) and is associated with increased risk for metastases to distant organs compared to other types of breast cancer [37,38,39,40,41]. The gene discussed is ERBB2; the disease is breast cancer.